{"transactions":[{"id":352,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":345,"kind":"person","name":"ADAMS JULIAN","position":1,"cik":"0001230486","reported_name":"ADAMS JULIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-02T20:05:26.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":21750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option represents the annual non-employee director equity award to the Reporting Person and shall vest and become exercisable in full on the earlier of (A) August 31, 2027, the one-year anniversary of the date of grant, and (B) the annual meeting of the Issuer's stockholders held in 2027, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. No additional equity award will be made to the Reporting Person in connection with the 2026 annual meeting of stockholders."}],"balance_after":21750,"derivative":{"exercise_price":2.7,"expiration_date":"2036-08-31","underlying":"Common Stock","underlying_shares":21750},"source":{"system":"sec-edgar","filing":"0001230486-26-000002","document":"wk-form4_1788379523.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000123048626000002/wk-form4_1788379523.xml","form_type":"4"}},{"id":338,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":323,"kind":"person","name":"Ashe Carol Gail","position":1,"cik":"0001761748","reported_name":"Ashe Carol Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-02T20:04:55.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":21750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option represents the annual non-employee director equity award to the Reporting Person and shall vest and become exercisable in full on the earlier of (A) August 31, 2027, the one-year anniversary of the date of grant, and (B) the annual meeting of the Issuer's stockholders held in 2027, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. No additional equity award will be made to the Reporting Person in connection with the 2026 annual meeting of stockholders."}],"balance_after":21750,"derivative":{"exercise_price":2.7,"expiration_date":"2036-08-31","underlying":"Common Stock","underlying_shares":21750},"source":{"system":"sec-edgar","filing":"0001761748-26-000002","document":"wk-form4_1788379493.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761748/000176174826000002/wk-form4_1788379493.xml","form_type":"4"}},{"id":334,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":318,"kind":"person","name":"Chudnovsky Yekaterina","position":1,"cik":"0001979324","reported_name":"Chudnovsky Yekaterina","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-02T20:04:28.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":21750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option represents the annual non-employee director equity award to the Reporting Person and shall vest and become exercisable in full on the earlier of (A) August 31, 2027, the one-year anniversary of the date of grant, and (B) the annual meeting of the Issuer's stockholders held in 2027, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. No additional equity award will be made to the Reporting Person in connection with the 2026 annual meeting of stockholders."}],"balance_after":21750,"derivative":{"exercise_price":2.7,"expiration_date":"2036-08-31","underlying":"Common Stock","underlying_shares":21750},"source":{"system":"sec-edgar","filing":"0001979324-26-000002","document":"wk-form4_1788379464.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1979324/000197932426000002/wk-form4_1788379464.xml","form_type":"4"}},{"id":329,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":312,"kind":"person","name":"Nissenson Allen","position":1,"cik":"0001441889","reported_name":"Nissenson Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-02T20:03:52.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":21750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option represents the annual non-employee director equity award to the Reporting Person and shall vest and become exercisable in full on the earlier of (A) August 31, 2027, the one-year anniversary of the date of grant, and (B) the annual meeting of the Issuer's stockholders held in 2027, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. No additional equity award will be made to the Reporting Person in connection with the 2026 annual meeting of stockholders."}],"balance_after":21750,"derivative":{"exercise_price":2.7,"expiration_date":"2036-08-31","underlying":"Common Stock","underlying_shares":21750},"source":{"system":"sec-edgar","filing":"0001441889-26-000002","document":"wk-form4_1788379430.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000144188926000002/wk-form4_1788379430.xml","form_type":"4"}},{"id":328,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":311,"kind":"person","name":"RUFFOLO ROBERT R","position":1,"cik":"0001187308","reported_name":"RUFFOLO ROBERT R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-02T20:03:22.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":21750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option represents the annual non-employee director equity award to the Reporting Person and shall vest and become exercisable in full on the earlier of (A) August 31, 2027, the one-year anniversary of the date of grant, and (B) the annual meeting of the Issuer's stockholders held in 2027, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. No additional equity award will be made to the Reporting Person in connection with the 2026 annual meeting of stockholders."}],"balance_after":21750,"derivative":{"exercise_price":2.7,"expiration_date":"2036-08-31","underlying":"Common Stock","underlying_shares":21750},"source":{"system":"sec-edgar","filing":"0001187308-26-000004","document":"wk-form4_1788379399.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000118730826000004/wk-form4_1788379399.xml","form_type":"4"}},{"id":320,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-02T20:03:02.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":21750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option represents the annual non-employee director equity award to the Reporting Person and shall vest and become exercisable in full on the earlier of (A) August 31, 2027, the one-year anniversary of the date of grant, and (B) the annual meeting of the Issuer's stockholders held in 2027, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. No additional equity award will be made to the Reporting Person in connection with the 2026 annual meeting of stockholders."}],"balance_after":21750,"derivative":{"exercise_price":2.7,"expiration_date":"2036-08-31","underlying":"Common Stock","underlying_shares":21750},"source":{"system":"sec-edgar","filing":"0001267490-26-000010","document":"wk-form4_1788379379.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000126749026000010/wk-form4_1788379379.xml","form_type":"4"}},{"id":315,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":300,"kind":"person","name":"Venkatesan Jay","position":1,"cik":"0001413350","reported_name":"Venkatesan Jay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-02T20:02:28.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":21750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option represents the annual non-employee director equity award to the Reporting Person and shall vest and become exercisable in full on the earlier of (A) August 31, 2027, the one-year anniversary of the date of grant, and (B) the annual meeting of the Issuer's stockholders held in 2027, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. No additional equity award will be made to the Reporting Person in connection with the 2026 annual meeting of stockholders."}],"balance_after":21750,"derivative":{"exercise_price":2.7,"expiration_date":"2036-08-31","underlying":"Common Stock","underlying_shares":21750},"source":{"system":"sec-edgar","filing":"0001413350-26-000009","document":"wk-form4_1788379344.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000141335026000009/wk-form4_1788379344.xml","form_type":"4"}},{"id":706816,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29759,"kind":"person","name":"Haqq Christopher","position":1,"cik":"0001612095","reported_name":"Haqq Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T20:14:39.000Z","date":"2026-07-16","kind":"grant","planned":false,"acquired":true,"shares":64643,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 50% of the options on July 16, 2027, the first anniversary of the grant date, and as to the remaining 50% of the options on July 16, 2028, the second anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":64643,"derivative":{"exercise_price":3.2,"expiration_date":"2036-07-16","underlying":"Common Stock","underlying_shares":64643},"source":{"system":"sec-edgar","filing":"0001612095-26-000002","document":"wk-form4_1784319276.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612095/000161209526000002/wk-form4_1784319276.xml","form_type":"4"}},{"id":706428,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29687,"kind":"person","name":"DeMuth Peter","position":1,"cik":"0001979163","reported_name":"DeMuth Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T20:14:05.000Z","date":"2026-07-16","kind":"grant","planned":false,"acquired":true,"shares":52832,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 50% of the options on July 16, 2027, the first anniversary of the grant date, and as to the remaining 50% of the options on July 16, 2028, the second anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":52832,"derivative":{"exercise_price":3.2,"expiration_date":"2036-07-16","underlying":"Common Stock","underlying_shares":52832},"source":{"system":"sec-edgar","filing":"0001979163-26-000002","document":"wk-form4_1784319242.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000197916326000002/wk-form4_1784319242.xml","form_type":"4"}},{"id":706426,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29685,"kind":"person","name":"Shah Preetam","position":1,"cik":"0001787403","reported_name":"Shah Preetam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T20:13:46.000Z","date":"2026-07-16","kind":"grant","planned":false,"acquired":true,"shares":60833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 50% of the options on July 16, 2027, the first anniversary of the grant date, and as to the remaining 50% of the options on July 16, 2028, the second anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":60833,"derivative":{"exercise_price":3.2,"expiration_date":"2036-07-16","underlying":"Common Stock","underlying_shares":60833},"source":{"system":"sec-edgar","filing":"0001787403-26-000002","document":"wk-form4_1784319224.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000178740326000002/wk-form4_1784319224.xml","form_type":"4"}},{"id":706425,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29684,"kind":"person","name":"Connelly Robert","position":1,"cik":"0001796436","reported_name":"Connelly Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T20:13:30.000Z","date":"2026-07-16","kind":"grant","planned":false,"acquired":true,"shares":186944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 50% of the options on July 16, 2027, the first anniversary of the grant date, and as to the remaining 50% of the options on July 16, 2028, the second anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":186944,"derivative":{"exercise_price":3.2,"expiration_date":"2036-07-16","underlying":"Common Stock","underlying_shares":186944},"source":{"system":"sec-edgar","filing":"0001796436-26-000002","document":"wk-form4_1784319208.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000179643626000002/wk-form4_1784319208.xml","form_type":"4"}},{"id":921043,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29684,"kind":"person","name":"Connelly Robert","position":1,"cik":"0001796436","reported_name":"Connelly Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-03T21:42:10.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":147200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable as to 25% of the options on February 2, 2027, the first anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":147200,"derivative":{"exercise_price":8.1,"expiration_date":"2036-02-02","underlying":"Common Stock","underlying_shares":147200},"source":{"system":"sec-edgar","filing":"0001601485-26-000010","document":"wk-form4_1770154928.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000160148526000010/wk-form4_1770154928.xml","form_type":"4"}},{"id":921042,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29684,"kind":"person","name":"Connelly Robert","position":1,"cik":"0001796436","reported_name":"Connelly Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Common Stock","published_at":"2026-02-03T21:42:10.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":73600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that will vest as to 25% of the RSUs on February 2, 2027, the first anniversary of the grant date, with the remaining RSUs vesting in annual installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Each RSU represents the right to receive one share of common stock, par value $0.01 per share, of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (\"RSUs\") that will vest as to 25% of the RSUs on February 2, 2027, the first anniversary of the grant date, with the remaining RSUs vesting in annual installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Each RSU represents the right to receive one share of common stock, par value $0.01 per share, of the Issuer."}],"balance_after":120570,"source":{"system":"sec-edgar","filing":"0001601485-26-000010","document":"wk-form4_1770154928.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000160148526000010/wk-form4_1770154928.xml","form_type":"4"}},{"id":921041,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29685,"kind":"person","name":"Shah Preetam","position":1,"cik":"0001787403","reported_name":"Shah Preetam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-03T21:40:15.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":47900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable as to 25% of the options on February 2, 2027, the first anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":47900,"derivative":{"exercise_price":8.1,"expiration_date":"2036-02-02","underlying":"Common Stock","underlying_shares":47900},"source":{"system":"sec-edgar","filing":"0001601485-26-000008","document":"wk-form4_1770154812.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000160148526000008/wk-form4_1770154812.xml","form_type":"4"}},{"id":921040,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29685,"kind":"person","name":"Shah Preetam","position":1,"cik":"0001787403","reported_name":"Shah Preetam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-03T21:40:15.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that will vest as to 25% of the RSUs on February 2, 2027, the first anniversary of the grant date, with the remaining RSUs vesting in annual installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Each RSU represents the right to receive one share of common stock, par value $0.01 per share, of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (\"RSUs\") that will vest as to 25% of the RSUs on February 2, 2027, the first anniversary of the grant date, with the remaining RSUs vesting in annual installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Each RSU represents the right to receive one share of common stock, par value $0.01 per share, of the Issuer."}],"balance_after":24000,"source":{"system":"sec-edgar","filing":"0001601485-26-000008","document":"wk-form4_1770154812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000160148526000008/wk-form4_1770154812.xml","form_type":"4"}},{"id":921039,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29687,"kind":"person","name":"DeMuth Peter","position":1,"cik":"0001979163","reported_name":"DeMuth Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-03T21:38:38.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":41600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable as to 25% of the options on February 2, 2027, the first anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":41600,"derivative":{"exercise_price":8.1,"expiration_date":"2036-02-02","underlying":"Common Stock","underlying_shares":41600},"source":{"system":"sec-edgar","filing":"0001601485-26-000006","document":"wk-form4_1770154713.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000160148526000006/wk-form4_1770154713.xml","form_type":"4"}},{"id":921038,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29687,"kind":"person","name":"DeMuth Peter","position":1,"cik":"0001979163","reported_name":"DeMuth Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-03T21:38:38.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":20800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that will vest as to 25% of the RSUs on February 2, 2027, the first anniversary of the grant date, with the remaining RSUs vesting in annual installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Each RSU represents the right to receive one share of common stock, par value $0.01 per share, of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (\"RSUs\") that will vest as to 25% of the RSUs on February 2, 2027, the first anniversary of the grant date, with the remaining RSUs vesting in annual installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Each RSU represents the right to receive one share of common stock, par value $0.01 per share, of the Issuer."}],"balance_after":21543,"source":{"system":"sec-edgar","filing":"0001601485-26-000006","document":"wk-form4_1770154713.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000160148526000006/wk-form4_1770154713.xml","form_type":"4"}},{"id":921808,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29759,"kind":"person","name":"Haqq Christopher","position":1,"cik":"0001612095","reported_name":"Haqq Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-03T21:33:56.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":50900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable as to 25% of the options on February 2, 2027, the first anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":50900,"derivative":{"exercise_price":8.1,"expiration_date":"2036-02-02","underlying":"Common Stock","underlying_shares":50900},"source":{"system":"sec-edgar","filing":"0001601485-26-000002","document":"wk-form4_1770154430.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1612095/000160148526000002/wk-form4_1770154430.xml","form_type":"4"}},{"id":921807,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29759,"kind":"person","name":"Haqq Christopher","position":1,"cik":"0001612095","reported_name":"Haqq Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-03T21:33:56.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":25400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that will vest as to 25% of the RSUs on February 2, 2027, the first anniversary of the grant date, with the remaining RSUs vesting in annual installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Each RSU represents the right to receive one share of common stock, par value $0.01 per share, of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (\"RSUs\") that will vest as to 25% of the RSUs on February 2, 2027, the first anniversary of the grant date, with the remaining RSUs vesting in annual installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Each RSU represents the right to receive one share of common stock, par value $0.01 per share, of the Issuer."}],"balance_after":57381,"source":{"system":"sec-edgar","filing":"0001601485-26-000002","document":"wk-form4_1770154430.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612095/000160148526000002/wk-form4_1770154430.xml","form_type":"4"}},{"id":974010,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29687,"kind":"person","name":"DeMuth Peter","position":1,"cik":"0001979163","reported_name":"DeMuth Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-10T22:05:36.000Z","date":"2025-12-09","kind":"exercise","planned":false,"acquired":false,"shares":362,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vested and became exercisable as to (i) 25% of the options on the first anniversary of the grant date or December 10, 2016, and (ii) with the remaining shares vesting at a rate of 2.0833% at the end of each month thereafter."}],"balance_after":0,"derivative":{"exercise_price":4.41,"expiration_date":"2025-12-10","underlying":"Common Stock","underlying_shares":362},"source":{"system":"sec-edgar","filing":"0001601485-25-000130","document":"wk-form4_1765404333.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000160148525000130/wk-form4_1765404333.xml","form_type":"4"}},{"id":974009,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29687,"kind":"person","name":"DeMuth Peter","position":1,"cik":"0001979163","reported_name":"DeMuth Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-10T22:05:36.000Z","date":"2025-12-09","kind":"exercise","planned":false,"acquired":true,"shares":362,"price":4.41,"value":1596.42,"ownership":{"direct":true},"balance_after":743,"source":{"system":"sec-edgar","filing":"0001601485-25-000130","document":"wk-form4_1765404333.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000160148525000130/wk-form4_1765404333.xml","form_type":"4"}},{"id":1122394,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":318,"kind":"person","name":"Chudnovsky Yekaterina","position":1,"cik":"0001979324","reported_name":"Chudnovsky Yekaterina","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78875,"kind":"organization","name":"GKCC, LLC","position":2,"cik":"0001977769","reported_name":"GKCC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-06-04T21:08:28.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":103225,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by GKCC, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Yekaterina (Katie) Chudnovsky is the sole member and manager of GKCC, LLC and may be deemed to beneficially own the shares held by GKCC, LLC."}],"balance_after":103225,"derivative":{"exercise_price":7.75,"exercise_date":"2025-06-03","expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":103225},"source":{"system":"sec-edgar","filing":"0000950170-25-081741","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000095017025081741/ownership.xml","form_type":"4"}},{"id":1140344,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":312,"kind":"person","name":"Nissenson Allen","position":1,"cik":"0001441889","reported_name":"Nissenson Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T20:07:35.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":7900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) May 19, 2026, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after\nthe grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) May 19, 2026, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after\nthe grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":7900,"derivative":{"exercise_price":5.84,"expiration_date":"2035-05-19","underlying":"Common Stock","underlying_shares":7900},"source":{"system":"sec-edgar","filing":"0001601485-25-000089","document":"wk-form4_1747771647.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441889/000160148525000089/wk-form4_1747771647.xml","form_type":"4"}},{"id":1140330,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":300,"kind":"person","name":"Venkatesan Jay","position":1,"cik":"0001413350","reported_name":"Venkatesan Jay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T20:07:13.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":7900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) May 19, 2026, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after\nthe grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) May 19, 2026, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after\nthe grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":7900,"derivative":{"exercise_price":5.84,"expiration_date":"2035-05-19","underlying":"Common Stock","underlying_shares":7900},"source":{"system":"sec-edgar","filing":"0001601485-25-000088","document":"wk-form4_1747771626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413350/000160148525000088/wk-form4_1747771626.xml","form_type":"4"}},{"id":1140270,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T20:06:29.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":7900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) May 19, 2026, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after\nthe grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) May 19, 2026, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after\nthe grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":7900,"derivative":{"exercise_price":5.84,"expiration_date":"2035-05-19","underlying":"Common Stock","underlying_shares":7900},"source":{"system":"sec-edgar","filing":"0001601485-25-000086","document":"wk-form4_1747771581.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000160148525000086/wk-form4_1747771581.xml","form_type":"4"}},{"id":1140238,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":311,"kind":"person","name":"RUFFOLO ROBERT R","position":1,"cik":"0001187308","reported_name":"RUFFOLO ROBERT R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T20:06:01.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":7900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) May 19, 2026, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after\nthe grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) May 19, 2026, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after\nthe grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":7900,"derivative":{"exercise_price":5.84,"expiration_date":"2035-05-19","underlying":"Common Stock","underlying_shares":7900},"source":{"system":"sec-edgar","filing":"0001601485-25-000085","document":"wk-form4_1747771551.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187308/000160148525000085/wk-form4_1747771551.xml","form_type":"4"}},{"id":1140036,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":318,"kind":"person","name":"Chudnovsky Yekaterina","position":1,"cik":"0001979324","reported_name":"Chudnovsky Yekaterina","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T20:05:37.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":7900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) May 19, 2026, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after\nthe grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) May 19, 2026, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after\nthe grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":7900,"derivative":{"exercise_price":5.84,"expiration_date":"2035-05-19","underlying":"Common Stock","underlying_shares":7900},"source":{"system":"sec-edgar","filing":"0001601485-25-000084","document":"wk-form4_1747771529.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000160148525000084/wk-form4_1747771529.xml","form_type":"4"}},{"id":1140515,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":323,"kind":"person","name":"Ashe Carol Gail","position":1,"cik":"0001761748","reported_name":"Ashe Carol Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T16:08:00.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":7900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) May 19, 2026, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after\nthe grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) May 19, 2026, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after\nthe grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":7900,"derivative":{"exercise_price":5.84,"expiration_date":"2035-05-19","underlying":"Common Stock","underlying_shares":7900},"source":{"system":"sec-edgar","filing":"0001601485-25-000090","document":"wk-form4_1747771672.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761748/000160148525000090/wk-form4_1747771672.xml","form_type":"4"}},{"id":1140219,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":345,"kind":"person","name":"ADAMS JULIAN","position":1,"cik":"0001230486","reported_name":"ADAMS JULIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T16:06:50.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":7900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) May 19, 2026, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after\nthe grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) May 19, 2026, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after\nthe grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":7900,"derivative":{"exercise_price":5.84,"expiration_date":"2035-05-19","underlying":"Common Stock","underlying_shares":7900},"source":{"system":"sec-edgar","filing":"0001601485-25-000087","document":"wk-form4_1747771603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230486/000160148525000087/wk-form4_1747771603.xml","form_type":"4"}},{"id":1170847,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29685,"kind":"person","name":"Shah Preetam","position":1,"cik":"0001787403","reported_name":"Shah Preetam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-16T21:12:23.000Z","date":"2025-04-15","kind":"grant","planned":false,"acquired":true,"shares":191624,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the options on March 24, 2025, the first anniversary of the Reporting Person's start date, with the remaining options vesting in equal monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":191624,"derivative":{"exercise_price":4.98,"expiration_date":"2035-04-15","underlying":"Common Stock","underlying_shares":191624},"source":{"system":"sec-edgar","filing":"0001601485-25-000065","document":"wk-form4_1744837936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000160148525000065/wk-form4_1744837936.xml","form_type":"4"}},{"id":1216848,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":318,"kind":"person","name":"Chudnovsky Yekaterina","position":1,"cik":"0001979324","reported_name":"Chudnovsky Yekaterina","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78875,"kind":"organization","name":"GKCC, LLC","position":2,"cik":"0001977769","reported_name":"GKCC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Note (convertible into Common Stock)","published_at":"2025-03-07T21:06:57.000Z","date":"2025-03-05","kind":"exercise","planned":false,"acquired":false,"shares":3442341,"price":5.81,"value":20000001.21,"ownership":{"direct":false,"nature":"Held by GKCC, LLC"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Convertible Note had a stated maturity date of February 15, 2026. The Convertible Note, including any accrued but unpaid interest, was converted into shares of Common Stock on March 5, 2025 at a conversion price of $5.81 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Convertible Note had a stated maturity date of February 15, 2026. The Convertible Note, including any accrued but unpaid interest, was converted into shares of Common Stock on March 5, 2025 at a conversion price of $5.81 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Yekaterina (Katie) Chudnovsky is the sole member and manager of GKCC, LLC and may be deemed to beneficially own the shares held by GKCC, LLC."}],"balance_after":0,"derivative":{"exercise_price":5.81,"underlying":"Common Stock","underlying_shares":3442341},"source":{"system":"sec-edgar","filing":"0000950170-25-035494","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000095017025035494/ownership.xml","form_type":"4"}},{"id":1216847,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":318,"kind":"person","name":"Chudnovsky Yekaterina","position":1,"cik":"0001979324","reported_name":"Chudnovsky Yekaterina","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78875,"kind":"organization","name":"GKCC, LLC","position":2,"cik":"0001977769","reported_name":"GKCC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-03-07T21:06:57.000Z","date":"2025-03-05","kind":"exercise","planned":false,"acquired":true,"shares":3500573,"price":5.81,"value":20338329.13,"ownership":{"direct":false,"nature":"Held by GKCC, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Yekaterina (Katie) Chudnovsky is the sole member and manager of GKCC, LLC and may be deemed to beneficially own the shares held by GKCC, LLC."}],"balance_after":5416212,"source":{"system":"sec-edgar","filing":"0000950170-25-035494","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000095017025035494/ownership.xml","form_type":"4"}},{"id":1283715,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29687,"kind":"person","name":"DeMuth Peter","position":1,"cik":"0001979163","reported_name":"DeMuth Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T21:11:31.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":44400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the options on the first anniversary of the grant date (February 3, 2026), with the remaining options vesting in equal monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":44400,"derivative":{"exercise_price":8.92,"expiration_date":"2035-02-03","underlying":"Common Stock","underlying_shares":44400},"source":{"system":"sec-edgar","filing":"0001601485-25-000016","document":"wk-form4_1738703480.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000160148525000016/wk-form4_1738703480.xml","form_type":"4"}},{"id":1284763,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29759,"kind":"person","name":"Haqq Christopher","position":1,"cik":"0001612095","reported_name":"Haqq Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T21:10:33.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the options on the first anniversary of the grant date (February 3, 2026), with the remaining options vesting in equal monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":44000,"derivative":{"exercise_price":8.92,"expiration_date":"2035-02-03","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001601485-25-000014","document":"wk-form4_1738703424.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612095/000160148525000014/wk-form4_1738703424.xml","form_type":"4"}},{"id":1283716,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29684,"kind":"person","name":"Connelly Robert","position":1,"cik":"0001796436","reported_name":"Connelly Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T21:08:31.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":121600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the options on the first anniversary of the grant date (February 3, 2026), with the remaining options vesting in equal monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":121600,"derivative":{"exercise_price":8.92,"expiration_date":"2035-02-03","underlying":"Common Stock","underlying_shares":121600},"source":{"system":"sec-edgar","filing":"0001601485-25-000012","document":"wk-form4_1738703302.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000160148525000012/wk-form4_1738703302.xml","form_type":"4"}},{"id":1318525,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":300,"kind":"person","name":"Venkatesan Jay","position":1,"cik":"0001413350","reported_name":"Venkatesan Jay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Pre-Funded Warrants","published_at":"2025-01-02T21:05:50.000Z","date":"2024-06-28","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":4.99,"value":249500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each Pre-Funded Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Pre-Funded Warrants do not have an expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"On July 2, 2024, the Reporting Person mistakenly filed a Form 4 reporting the acquisition of an additional 150,000 Common Warrants and 150,000 Pre-Funded Warrants. The Reporting Person is not the beneficial owner of such Common Warrants or Pre-Funded Warrants. As of January 2, 2025, the Reporting Person owned only the Common Warrants and Pre-Funded Warrants reported herein."}],"balance_after":50000,"derivative":{"exercise_price":0.01,"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001601485-25-000002","document":"wk-form4a_1735851944.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1413350/000160148525000002/wk-form4a_1735851944.xml","form_type":"4/A","original_submission_date":"2024-07-02"}},{"id":1318524,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":300,"kind":"person","name":"Venkatesan Jay","position":1,"cik":"0001413350","reported_name":"Venkatesan Jay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Warrants","published_at":"2025-01-02T21:05:50.000Z","date":"2024-06-28","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Common Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $5.00 per share, subject to adjustments as provided under the terms of the Common Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Common Warrants expire on July 1, 2029."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"On July 2, 2024, the Reporting Person mistakenly filed a Form 4 reporting the acquisition of an additional 150,000 Common Warrants and 150,000 Pre-Funded Warrants. The Reporting Person is not the beneficial owner of such Common Warrants or Pre-Funded Warrants. As of January 2, 2025, the Reporting Person owned only the Common Warrants and Pre-Funded Warrants reported herein."}],"balance_after":50000,"derivative":{"exercise_price":5,"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001601485-25-000002","document":"wk-form4a_1735851944.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413350/000160148525000002/wk-form4a_1735851944.xml","form_type":"4/A","original_submission_date":"2024-07-02"}},{"id":1326221,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29687,"kind":"person","name":"DeMuth Peter","position":1,"cik":"0001979163","reported_name":"DeMuth Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-18T21:51:33.000Z","date":"2024-12-16","kind":"exercise","planned":false,"acquired":false,"shares":381,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vested and became exercisable as to (i) 25% of the options on the first anniversary of the grant date or December 18, 2015, and (ii) with the remaining shares vesting at a rate of 2.0833% at the end of each month thereafter."}],"balance_after":0,"derivative":{"exercise_price":4.41,"expiration_date":"2024-12-18","underlying":"Common Stock","underlying_shares":381},"source":{"system":"sec-edgar","filing":"0001601485-24-000109","document":"wk-form4_1734558687.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000160148524000109/wk-form4_1734558687.xml","form_type":"4"}},{"id":1326220,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29687,"kind":"person","name":"DeMuth Peter","position":1,"cik":"0001979163","reported_name":"DeMuth Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-12-18T21:51:33.000Z","date":"2024-12-16","kind":"exercise","planned":false,"acquired":true,"shares":381,"price":4.41,"value":1680.21,"ownership":{"direct":true},"balance_after":381,"source":{"system":"sec-edgar","filing":"0001601485-24-000109","document":"wk-form4_1734558687.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000160148524000109/wk-form4_1734558687.xml","form_type":"4"}},{"id":1348338,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":300,"kind":"person","name":"Venkatesan Jay","position":1,"cik":"0001413350","reported_name":"Venkatesan Jay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2024-11-29T12:39:46.000Z","date":"2024-11-26","kind":"other","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"N/A"}],"balance_after":0,"derivative":{"exercise_price":0.01,"exercise_date":"2024-07-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001601485-24-000105","document":"wk-form4_1732883980.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1413350/000160148524000105/wk-form4_1732883980.xml","form_type":"4"}},{"id":1348337,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":300,"kind":"person","name":"Venkatesan Jay","position":1,"cik":"0001413350","reported_name":"Venkatesan Jay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-29T12:39:46.000Z","date":"2024-11-26","kind":"other","planned":false,"acquired":true,"shares":50000,"price":0.01,"value":500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 26, 2024, the Reporting Person exercised a pre-funded warrant to purchase an aggregate of 50,000 shares of the Issuer's common stock."}],"balance_after":179581,"source":{"system":"sec-edgar","filing":"0001601485-24-000105","document":"wk-form4_1732883980.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413350/000160148524000105/wk-form4_1732883980.xml","form_type":"4"}},{"id":1352524,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-25T21:05:27.000Z","date":"2024-11-21","kind":"grant","planned":false,"acquired":true,"shares":4100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) November 21, 2025, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after the grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) November 21, 2025, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after the grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":4100,"derivative":{"exercise_price":5.12,"expiration_date":"2034-11-21","underlying":"Common Stock","underlying_shares":4100},"source":{"system":"sec-edgar","filing":"0001601485-24-000101","document":"wk-form4_1732568717.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000160148524000101/wk-form4_1732568717.xml","form_type":"4"}},{"id":1352553,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":300,"kind":"person","name":"Venkatesan Jay","position":1,"cik":"0001413350","reported_name":"Venkatesan Jay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-25T12:35:21.000Z","date":"2024-11-21","kind":"grant","planned":false,"acquired":true,"shares":4100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) November 21, 2025, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after the grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) November 21, 2025, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after the grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":4100,"derivative":{"exercise_price":5.12,"expiration_date":"2034-11-21","underlying":"Common Stock","underlying_shares":4100},"source":{"system":"sec-edgar","filing":"0001601485-24-000095","document":"wk-form4_1732538114.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413350/000160148524000095/wk-form4_1732538114.xml","form_type":"4"}},{"id":1352503,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":311,"kind":"person","name":"RUFFOLO ROBERT R","position":1,"cik":"0001187308","reported_name":"RUFFOLO ROBERT R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-25T12:34:21.000Z","date":"2024-11-21","kind":"grant","planned":false,"acquired":true,"shares":4100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) November 21, 2025, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after the grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) November 21, 2025, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after the grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":4100,"derivative":{"exercise_price":5.12,"expiration_date":"2034-11-21","underlying":"Common Stock","underlying_shares":4100},"source":{"system":"sec-edgar","filing":"0001601485-24-000093","document":"wk-form4_1732538054.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187308/000160148524000093/wk-form4_1732538054.xml","form_type":"4"}},{"id":1352331,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":318,"kind":"person","name":"Chudnovsky Yekaterina","position":1,"cik":"0001979324","reported_name":"Chudnovsky Yekaterina","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-25T12:33:19.000Z","date":"2024-11-21","kind":"grant","planned":false,"acquired":true,"shares":4100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) November 21, 2025, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after the grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) November 21, 2025, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after the grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":4100,"derivative":{"exercise_price":5.12,"expiration_date":"2034-11-21","underlying":"Common Stock","underlying_shares":4100},"source":{"system":"sec-edgar","filing":"0001601485-24-000091","document":"wk-form4_1732537993.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000160148524000091/wk-form4_1732537993.xml","form_type":"4"}},{"id":1352595,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":312,"kind":"person","name":"Nissenson Allen","position":1,"cik":"0001441889","reported_name":"Nissenson Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-25T12:32:21.000Z","date":"2024-11-21","kind":"grant","planned":false,"acquired":true,"shares":4100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) November 21, 2025, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after the grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) November 21, 2025, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after the grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":4100,"derivative":{"exercise_price":5.12,"expiration_date":"2034-11-21","underlying":"Common Stock","underlying_shares":4100},"source":{"system":"sec-edgar","filing":"0001601485-24-000089","document":"wk-form4_1732537934.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441889/000160148524000089/wk-form4_1732537934.xml","form_type":"4"}},{"id":1352471,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":345,"kind":"person","name":"ADAMS JULIAN","position":1,"cik":"0001230486","reported_name":"ADAMS JULIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-25T07:37:17.000Z","date":"2024-11-21","kind":"grant","planned":false,"acquired":true,"shares":4100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) November 21, 2025, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after the grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) November 21, 2025, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after the grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":4100,"derivative":{"exercise_price":5.12,"expiration_date":"2034-11-21","underlying":"Common Stock","underlying_shares":4100},"source":{"system":"sec-edgar","filing":"0001601485-24-000099","document":"wk-form4_1732538230.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230486/000160148524000099/wk-form4_1732538230.xml","form_type":"4"}},{"id":1352794,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":323,"kind":"person","name":"Ashe Carol Gail","position":1,"cik":"0001761748","reported_name":"Ashe Carol Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-25T07:36:14.000Z","date":"2024-11-21","kind":"grant","planned":false,"acquired":true,"shares":4100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) November 21, 2025, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after the grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) November 21, 2025, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after the grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":4100,"derivative":{"exercise_price":5.12,"expiration_date":"2034-11-21","underlying":"Common Stock","underlying_shares":4100},"source":{"system":"sec-edgar","filing":"0001601485-24-000097","document":"wk-form4_1732538168.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761748/000160148524000097/wk-form4_1732538168.xml","form_type":"4"}},{"id":1393703,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29684,"kind":"person","name":"Connelly Robert","position":1,"cik":"0001796436","reported_name":"Connelly Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-02T20:14:33.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":91600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fifty percent (50%) of the stock options vest on September 30, 2025, the one-year anniversary of the grant date, with the remaining fifty percent (50%) of the stock options to vest on September 30, 2026, the two-year anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":91600,"derivative":{"exercise_price":5.03,"expiration_date":"2034-09-30","underlying":"Common Stock","underlying_shares":91600},"source":{"system":"sec-edgar","filing":"0001601485-24-000053","document":"wk-form4_1727900067.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000160148524000053/wk-form4_1727900067.xml","form_type":"4"}},{"id":1393701,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29687,"kind":"person","name":"DeMuth Peter","position":1,"cik":"0001979163","reported_name":"DeMuth Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-02T20:13:23.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":29800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fifty percent (50%) of the stock options vest on September 30, 2025, the one-year anniversary of the grant date, with the remaining fifty percent (50%) of the stock options to vest on September 30, 2026, the two-year anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":29800,"derivative":{"exercise_price":5.03,"expiration_date":"2024-09-30","underlying":"Common Stock","underlying_shares":29800},"source":{"system":"sec-edgar","filing":"0001601485-24-000051","document":"wk-form4_1727899996.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000160148524000051/wk-form4_1727899996.xml","form_type":"4"}},{"id":1394410,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29759,"kind":"person","name":"Haqq Christopher","position":1,"cik":"0001612095","reported_name":"Haqq Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-02T20:12:12.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":28200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fifty percent (50%) of the stock options vest on September 30, 2025, the one-year anniversary of the grant date, with the remaining fifty percent (50%) of the stock options to vest on September 30, 2026, the two-year anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."}],"balance_after":28200,"derivative":{"exercise_price":5.03,"expiration_date":"2024-09-30","underlying":"Common Stock","underlying_shares":28200},"source":{"system":"sec-edgar","filing":"0001601485-24-000049","document":"wk-form4_1727899926.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612095/000160148524000049/wk-form4_1727899926.xml","form_type":"4"}},{"id":1433341,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":318,"kind":"person","name":"Chudnovsky Yekaterina","position":1,"cik":"0001979324","reported_name":"Chudnovsky Yekaterina","relationship":{"director":true,"ten_percent_owner":true}},{"id":78875,"kind":"organization","name":"GKCC, LLC","position":2,"cik":"0001977769","reported_name":"GKCC, LLC","relationship":{"ten_percent_owner":true}}],"security":"Convertible Note (convertible into Common Stock)","published_at":"2024-08-14T20:41:38.000Z","date":"2024-08-12","kind":"purchase","planned":false,"acquired":true,"shares":3442341,"price":5.81,"value":20000001.21,"ownership":{"direct":false,"nature":"Held by GKCC, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 12, 2024, GKCC, LLC (the \"Purchaser\") purchased from the Issuer a convertible note with an aggregate principal amount of $20,000,000 (the \"Convertible Note\"). The Convertible Note is convertible into shares of common stock of the Issuer at a conversion price of $5.81 per share, subject to adjustment in certain circumstances. Therefore, the Convertible Note is initially convertible into approximately 3,442,341 shares of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Convertible Note will mature on February 15, 2026, unless earlier converted in accordance with the terms of the Convertible Note. Interest on the Convertible Note is payable in cash and will accrue and be payable quarterly on the principal amount equal to 3% per annum."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Convertible Note will mature on February 15, 2026, unless earlier converted in accordance with the terms of the Convertible Note. Interest on the Convertible Note is payable in cash and will accrue and be payable quarterly on the principal amount equal to 3% per annum."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Yekaterina (Katie) Chudnovsky is the sole member and manager of the Purchaser and may be deemed to beneficially own the shares held by the Purchaser."}],"balance_after":3442341,"derivative":{"exercise_price":5.81,"underlying":"Common Stock","underlying_shares":3442341},"source":{"system":"sec-edgar","filing":"0001140361-24-037346","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000114036124037346/form4.xml","form_type":"4"}},{"id":1462628,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":300,"kind":"person","name":"Venkatesan Jay","position":1,"cik":"0001413350","reported_name":"Venkatesan Jay","relationship":{"director":true}}],"security":"Pre-Funded Warrants","published_at":"2024-07-03T01:53:20.000Z","date":"2024-06-28","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":4.99,"value":249500.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Pre-Funded Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Pre-Funded Warrants do not have an expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Reporting Person may be deemed to have shared voting and investment power over the trust which holds these securities. A Member of the Reporting Person's immediate family is the beneficiary of the trust which holds these securities. The Reporting Person disclaims beneficial ownership of the securities held by the trust which holds these securities except to the extent of his pecuniary interest therein, if any."}],"balance_after":50000,"derivative":{"exercise_price":0.01,"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001140361-24-032293","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1413350/000114036124032293/form4.xml","form_type":"4"}},{"id":1462627,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":300,"kind":"person","name":"Venkatesan Jay","position":1,"cik":"0001413350","reported_name":"Venkatesan Jay","relationship":{"director":true}}],"security":"Common Warrants","published_at":"2024-07-03T01:53:20.000Z","date":"2024-06-28","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Common Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $5.00 per share, subject to adjustments as provided under the terms of the Common Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Common Warrants expire on July 1, 2029."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Reporting Person may be deemed to have shared voting and investment power over the trust which holds these securities. A Member of the Reporting Person's immediate family is the beneficiary of the trust which holds these securities. The Reporting Person disclaims beneficial ownership of the securities held by the trust which holds these securities except to the extent of his pecuniary interest therein, if any."}],"balance_after":50000,"derivative":{"exercise_price":5,"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001140361-24-032293","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1413350/000114036124032293/form4.xml","form_type":"4"}},{"id":1462626,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":300,"kind":"person","name":"Venkatesan Jay","position":1,"cik":"0001413350","reported_name":"Venkatesan Jay","relationship":{"director":true}}],"security":"Pre-Funded Warrants","published_at":"2024-07-03T01:53:20.000Z","date":"2024-06-28","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":4.99,"value":249500.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Pre-Funded Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Pre-Funded Warrants do not have an expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Reporting Person may be deemed to have shared voting and investment power over the trust which holds these securities. A Member of the Reporting Person's immediate family is the beneficiary of the trust which holds these securities. The Reporting Person disclaims beneficial ownership of the securities held by the trust which holds these securities except to the extent of his pecuniary interest therein, if any."}],"balance_after":50000,"derivative":{"exercise_price":0.01,"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001140361-24-032293","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1413350/000114036124032293/form4.xml","form_type":"4"}},{"id":1462625,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":300,"kind":"person","name":"Venkatesan Jay","position":1,"cik":"0001413350","reported_name":"Venkatesan Jay","relationship":{"director":true}}],"security":"Common Warrants","published_at":"2024-07-03T01:53:20.000Z","date":"2024-06-28","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Common Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $5.00 per share, subject to adjustments as provided under the terms of the Common Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Common Warrants expire on July 1, 2029."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Reporting Person may be deemed to have shared voting and investment power over the trust which holds these securities. A Member of the Reporting Person's immediate family is the beneficiary of the trust which holds these securities. The Reporting Person disclaims beneficial ownership of the securities held by the trust which holds these securities except to the extent of his pecuniary interest therein, if any."}],"balance_after":50000,"derivative":{"exercise_price":5,"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001140361-24-032293","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1413350/000114036124032293/form4.xml","form_type":"4"}},{"id":1462624,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":300,"kind":"person","name":"Venkatesan Jay","position":1,"cik":"0001413350","reported_name":"Venkatesan Jay","relationship":{"director":true}}],"security":"Pre-Funded Warrants","published_at":"2024-07-03T01:53:20.000Z","date":"2024-06-28","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":4.99,"value":249500.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Pre-Funded Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Pre-Funded Warrants do not have an expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Reporting Person may be deemed to have shared voting and investment power over the trust which holds these securities. A Member of the Reporting Person's immediate family is the beneficiary of the trust which holds these securities. The Reporting Person disclaims beneficial ownership of the securities held by the trust which holds these securities except to the extent of his pecuniary interest therein, if any."}],"balance_after":50000,"derivative":{"exercise_price":0.01,"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001140361-24-032293","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1413350/000114036124032293/form4.xml","form_type":"4"}},{"id":1462623,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":300,"kind":"person","name":"Venkatesan Jay","position":1,"cik":"0001413350","reported_name":"Venkatesan Jay","relationship":{"director":true}}],"security":"Common Warrants","published_at":"2024-07-03T01:53:20.000Z","date":"2024-06-28","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Common Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $5.00 per share, subject to adjustments as provided under the terms of the Common Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Common Warrants expire on July 1, 2029."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Reporting Person may be deemed to have shared voting and investment power over the trust which holds these securities. A Member of the Reporting Person's immediate family is the beneficiary of the trust which holds these securities. The Reporting Person disclaims beneficial ownership of the securities held by the trust which holds these securities except to the extent of his pecuniary interest therein, if any."}],"balance_after":50000,"derivative":{"exercise_price":5,"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001140361-24-032293","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1413350/000114036124032293/form4.xml","form_type":"4"}},{"id":1462622,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":300,"kind":"person","name":"Venkatesan Jay","position":1,"cik":"0001413350","reported_name":"Venkatesan Jay","relationship":{"director":true}}],"security":"Pre-Funded Warrants","published_at":"2024-07-03T01:53:20.000Z","date":"2024-06-28","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":4.99,"value":249500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Pre-Funded Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Pre-Funded Warrants do not have an expiration date."}],"balance_after":50000,"derivative":{"exercise_price":0.01,"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001140361-24-032293","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1413350/000114036124032293/form4.xml","form_type":"4"}},{"id":1462621,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":300,"kind":"person","name":"Venkatesan Jay","position":1,"cik":"0001413350","reported_name":"Venkatesan Jay","relationship":{"director":true}}],"security":"Common Warrants","published_at":"2024-07-03T01:53:20.000Z","date":"2024-06-28","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Common Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $5.00 per share, subject to adjustments as provided under the terms of the Common Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Common Warrants expire on July 1, 2029."}],"balance_after":50000,"derivative":{"exercise_price":5,"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001140361-24-032293","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413350/000114036124032293/form4.xml","form_type":"4"}},{"id":1462090,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":318,"kind":"person","name":"Chudnovsky Yekaterina","position":1,"cik":"0001979324","reported_name":"Chudnovsky Yekaterina","relationship":{"director":true,"ten_percent_owner":true}},{"id":78875,"kind":"organization","name":"GKCC, LLC","position":2,"cik":"0001977769","reported_name":"GKCC, LLC","relationship":{"ten_percent_owner":true}}],"security":"Pre-Funded Warrants","published_at":"2024-07-02T20:30:42.000Z","date":"2024-06-28","kind":"purchase","planned":false,"acquired":true,"shares":1600000,"price":4.99,"value":7984000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Pre-Funded Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 19.99%."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Pre-Funded Warrants do not have an expiration date."}],"balance_after":1600000,"derivative":{"exercise_price":0.01,"underlying":"Common Stock","underlying_shares":1600000},"source":{"system":"sec-edgar","filing":"0001140361-24-032163","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000114036124032163/form4.xml","form_type":"4"}},{"id":1462089,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":318,"kind":"person","name":"Chudnovsky Yekaterina","position":1,"cik":"0001979324","reported_name":"Chudnovsky Yekaterina","relationship":{"director":true,"ten_percent_owner":true}},{"id":78875,"kind":"organization","name":"GKCC, LLC","position":2,"cik":"0001977769","reported_name":"GKCC, LLC","relationship":{"ten_percent_owner":true}}],"security":"Common Warrants","published_at":"2024-07-02T20:30:42.000Z","date":"2024-06-28","kind":"purchase","planned":false,"acquired":true,"shares":1600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Common Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $5.00 per share, subject to adjustments as provided under the terms of the Common Warrant, subject to a post-exercise beneficial ownership limitation of 19.99%."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Common Warrants expire on July 1, 2029."}],"balance_after":1600000,"derivative":{"exercise_price":5,"underlying":"Common Stock","underlying_shares":1600000},"source":{"system":"sec-edgar","filing":"0001140361-24-032163","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000114036124032163/form4.xml","form_type":"4"}},{"id":1565709,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":318,"kind":"person","name":"Chudnovsky Yekaterina","position":1,"cik":"0001979324","reported_name":"Chudnovsky Yekaterina","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78875,"kind":"organization","name":"GKCC, LLC","position":2,"cik":"0001977769","reported_name":"GKCC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Common Stock Purchase Warrant","published_at":"2024-03-20T20:28:11.000Z","date":"2024-03-19","kind":"purchase","planned":false,"acquired":true,"shares":1032702,"price":5.81,"value":5999998.62,"ownership":{"direct":false,"nature":"Held by GKCC, LLC"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Pre-Funded Warrant will be exercisable by GKCC, LLC at any time on or after March 19, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 19.99%, unless stockholder approval is obtained."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Pre-Funded Warrants do not have an expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Yekaterina (Katie) Chudnovsky is the sole member and manager of GKCC, LLC and may be deemed to beneficially own the shares held by GKCC, LLC."}],"balance_after":1032702,"derivative":{"exercise_price":0.01,"underlying":"Common Stock","underlying_shares":1032702},"source":{"system":"sec-edgar","filing":"0000950170-24-034198","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000095017024034198/ownership.xml","form_type":"4"}},{"id":1659723,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":39434,"kind":"person","name":"Piekos Brian","position":1,"cik":"0001815308","reported_name":"Piekos Brian","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-05T11:01:51.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":43225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty five percent (25%) of the stock options vest on February 1, 2025, the one-year anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":43225,"derivative":{"exercise_price":4.5,"expiration_date":"2034-02-01","underlying":"Common Stock","underlying_shares":43225},"source":{"system":"sec-edgar","filing":"0001140361-24-005499","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815308/000114036124005499/form4.xml","form_type":"4"}},{"id":1658168,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29684,"kind":"person","name":"Connelly Robert","position":1,"cik":"0001796436","reported_name":"Connelly Robert","relationship":{"director":true,"officer":true,"officer_title":"CEO, President and Director"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-05T11:01:44.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":225137,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty five percent (25%) of the stock options vest on February 1, 2025, the one-year anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":225137,"derivative":{"exercise_price":4.5,"expiration_date":"2034-02-01","underlying":"Common Stock","underlying_shares":225137},"source":{"system":"sec-edgar","filing":"0001140361-24-005498","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000114036124005498/form4.xml","form_type":"4"}},{"id":1658814,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29759,"kind":"person","name":"Haqq Christopher","position":1,"cik":"0001612095","reported_name":"Haqq Christopher","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-05T11:01:41.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":28200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty five percent (25%) of the stock options vest on February 1, 2025, the one-year anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":28200,"derivative":{"exercise_price":4.5,"expiration_date":"2034-02-01","underlying":"Common Stock","underlying_shares":28200},"source":{"system":"sec-edgar","filing":"0001140361-24-005497","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612095/000114036124005497/form4.xml","form_type":"4"}},{"id":1658167,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29687,"kind":"person","name":"DeMuth Peter","position":1,"cik":"0001979163","reported_name":"DeMuth Peter","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-05T11:01:39.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":342,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vested in full on February 1, 2024."}],"balance_after":342,"derivative":{"exercise_price":4.5,"expiration_date":"2034-02-01","underlying":"Common Stock","underlying_shares":342},"source":{"system":"sec-edgar","filing":"0001140361-24-005496","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000114036124005496/form4.xml","form_type":"4"}},{"id":1658166,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29687,"kind":"person","name":"DeMuth Peter","position":1,"cik":"0001979163","reported_name":"DeMuth Peter","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-05T11:01:39.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":29800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty five percent (25%) of the stock options vest on February 1, 2025, the one-year anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":29800,"derivative":{"exercise_price":4.5,"expiration_date":"2034-02-01","underlying":"Common Stock","underlying_shares":29800},"source":{"system":"sec-edgar","filing":"0001140361-24-005496","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000114036124005496/form4.xml","form_type":"4"}},{"id":1697876,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":312,"kind":"person","name":"Nissenson Allen","position":1,"cik":"0001441889","reported_name":"Nissenson Allen","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-12-29T22:05:51.000Z","date":"2023-12-28","kind":"grant","planned":false,"acquired":true,"shares":4100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":4100,"derivative":{"exercise_price":8.26,"expiration_date":"2033-12-28","underlying":"Common Stock","underlying_shares":4100},"source":{"system":"sec-edgar","filing":"0001140361-23-060239","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441889/000114036123060239/form4.xml","form_type":"4"}},{"id":1697742,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":318,"kind":"person","name":"Chudnovsky Yekaterina","position":1,"cik":"0001979324","reported_name":"Chudnovsky Yekaterina","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (right to buy)","published_at":"2023-12-29T22:05:50.000Z","date":"2023-12-28","kind":"grant","planned":false,"acquired":true,"shares":4100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":4100,"derivative":{"exercise_price":8.26,"expiration_date":"2033-12-28","underlying":"Common Stock","underlying_shares":4100},"source":{"system":"sec-edgar","filing":"0001140361-23-060238","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000114036123060238/form4.xml","form_type":"4"}},{"id":1697847,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-12-29T22:05:46.000Z","date":"2023-12-28","kind":"grant","planned":false,"acquired":true,"shares":4100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":4100,"derivative":{"exercise_price":8.26,"expiration_date":"2033-12-28","underlying":"Common Stock","underlying_shares":4100},"source":{"system":"sec-edgar","filing":"0001140361-23-060237","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000114036123060237/form4.xml","form_type":"4"}},{"id":1697865,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":300,"kind":"person","name":"Venkatesan Jay","position":1,"cik":"0001413350","reported_name":"Venkatesan Jay","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-12-29T22:05:40.000Z","date":"2023-12-28","kind":"grant","planned":false,"acquired":true,"shares":4100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":4100,"derivative":{"exercise_price":8.26,"expiration_date":"2033-12-28","underlying":"Common Stock","underlying_shares":4100},"source":{"system":"sec-edgar","filing":"0001140361-23-060235","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413350/000114036123060235/form4.xml","form_type":"4"}},{"id":1697830,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":311,"kind":"person","name":"RUFFOLO ROBERT R","position":1,"cik":"0001187308","reported_name":"RUFFOLO ROBERT R","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-12-29T22:05:33.000Z","date":"2023-12-28","kind":"grant","planned":false,"acquired":true,"shares":4100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":4100,"derivative":{"exercise_price":8.26,"expiration_date":"2033-12-28","underlying":"Common Stock","underlying_shares":4100},"source":{"system":"sec-edgar","filing":"0001140361-23-060233","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187308/000114036123060233/form4.xml","form_type":"4"}},{"id":1697828,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":345,"kind":"person","name":"ADAMS JULIAN","position":1,"cik":"0001230486","reported_name":"ADAMS JULIAN","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-12-29T17:05:43.000Z","date":"2023-12-28","kind":"grant","planned":false,"acquired":true,"shares":4100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":4100,"derivative":{"exercise_price":8.26,"expiration_date":"2033-12-28","underlying":"Common Stock","underlying_shares":4100},"source":{"system":"sec-edgar","filing":"0001140361-23-060234","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230486/000114036123060234/form4.xml","form_type":"4"}},{"id":1697993,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":323,"kind":"person","name":"Ashe Carol Gail","position":1,"cik":"0001761748","reported_name":"Ashe Carol Gail","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-12-29T17:05:36.000Z","date":"2023-12-28","kind":"grant","planned":false,"acquired":true,"shares":4100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":4100,"derivative":{"exercise_price":8.26,"expiration_date":"2033-12-28","underlying":"Common Stock","underlying_shares":4100},"source":{"system":"sec-edgar","filing":"0001140361-23-060236","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761748/000114036123060236/form4.xml","form_type":"4"}},{"id":1699971,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":318,"kind":"person","name":"Chudnovsky Yekaterina","position":1,"cik":"0001979324","reported_name":"Chudnovsky Yekaterina","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78875,"kind":"organization","name":"GKCC, LLC","position":2,"cik":"0001977769","reported_name":"GKCC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-12-26T21:29:30.000Z","date":"2023-12-22","kind":"purchase","planned":false,"acquired":true,"shares":1213000,"price":5.81,"value":7047530.0,"ownership":{"direct":false,"nature":"Held by GKCC, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Yekaterina (Katie) Chudnovsky is the sole member and manager of GKCC, LLC and may be deemed to beneficially own the shares held by GKCC, LLC."}],"balance_after":1915639,"source":{"system":"sec-edgar","filing":"0001209191-23-059683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000120919123059683/doc4.xml","form_type":"4"}},{"id":1868163,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":39434,"kind":"person","name":"Piekos Brian","position":1,"cik":"0001815308","reported_name":"Piekos Brian","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-06-05T21:25:16.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":75484,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the option shares on May 15, 2024 with the remainder vesting in 36 equal monthly installments at the end of each month thereafter, subject to the Reporting Person continuing to provide services to the Issuer through the applicable vesting dates, and provided that in the event there is a change in control of the Issuer, followed by a subsequent termination of the Reporting Person's employment without cause (or a material diminishment of his role) within 12 months of the change of control, any unvested options granted will immediately vest."}],"balance_after":75484,"derivative":{"exercise_price":10,"expiration_date":"2033-06-01","underlying":"Common Stock","underlying_shares":75484},"source":{"system":"sec-edgar","filing":"0001140361-23-028420","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815308/000114036123028420/form4.xml","form_type":"4"}},{"id":2209204,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":125451,"kind":"person","name":"Goldberg Itzhak","position":1,"cik":"0001607858","reported_name":"Goldberg Itzhak","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-11T19:54:25.000Z","date":"2022-07-01","kind":"tax_withholding","acquired":false,"shares":32082,"price":1.12,"value":35931.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were withheld to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units (\"RSUs\")."}],"balance_after":1687986,"source":{"system":"sec-edgar","filing":"0001601485-22-000059","document":"wf-form4_165758365151556.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607858/000160148522000059/wf-form4_165758365151556.xml","form_type":"4"}},{"id":2234064,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":312,"kind":"person","name":"Nissenson Allen","position":1,"cik":"0001441889","reported_name":"Nissenson Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T21:26:52.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1.To vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.73,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001601485-22-000052","document":"wf-form4_165515558808558.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441889/000160148522000052/wf-form4_165515558808558.xml","form_type":"4"}},{"id":2233900,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":308,"kind":"person","name":"WILSON KAREN J","position":1,"cik":"0001267490","reported_name":"WILSON KAREN J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T21:26:25.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1.To vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.73,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001601485-22-000051","document":"wf-form4_165515557133787.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267490/000160148522000051/wf-form4_165515557133787.xml","form_type":"4"}},{"id":2233870,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":12607,"kind":"person","name":"OMENN GILBERT S","position":1,"cik":"0001184227","reported_name":"OMENN GILBERT S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T21:26:07.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1.To vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.73,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001601485-22-000050","document":"wf-form4_165515555115849.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1184227/000160148522000050/wf-form4_165515555115849.xml","form_type":"4"}},{"id":2233853,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":66172,"kind":"person","name":"GANZI VICTOR F","position":1,"cik":"0001199070","reported_name":"GANZI VICTOR F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T17:27:20.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1.To vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.73,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001601485-22-000053","document":"wf-form4_165515561728971.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1199070/000160148522000053/wf-form4_165515561728971.xml","form_type":"4"}},{"id":2253209,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":300,"kind":"person","name":"Venkatesan Jay","position":1,"cik":"0001413350","reported_name":"Venkatesan Jay","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Warrant to Purchase Common Stock","published_at":"2022-05-27T20:20:09.000Z","date":"2021-02-09","kind":"other","acquired":false,"shares":396329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 9, 2021 the Reporting Person exercised a warrant to purchase an aggregate of 396,329 shares of the Issuer's common stock for $6.43 a share. The Reporting Person paid the exercise price on a cashless basis, resulting in the issuer's withholding of 159,177 of the warrant shares to pay the exercise price and issuing to the Reporting Person the remaining 237,152 shares of common stock."}],"balance_after":0,"derivative":{"exercise_price":6.43,"expiration_date":"2028-07-05","underlying":"Common Stock","underlying_shares":396329},"source":{"system":"sec-edgar","filing":"0001601485-22-000045","document":"wf-form4a_165368278065712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1413350/000160148522000045/wf-form4a_165368278065712.xml","form_type":"4/A","original_submission_date":"2021-02-11"}},{"id":2253208,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":300,"kind":"person","name":"Venkatesan Jay","position":1,"cik":"0001413350","reported_name":"Venkatesan Jay","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-05-27T20:20:09.000Z","date":"2021-02-09","kind":"exercise","acquired":true,"shares":262,"price":11.57,"value":3031.34,"ownership":{"direct":true},"balance_after":1439525,"source":{"system":"sec-edgar","filing":"0001601485-22-000045","document":"wf-form4a_165368278065712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1413350/000160148522000045/wf-form4a_165368278065712.xml","form_type":"4/A","original_submission_date":"2021-02-11"}},{"id":2253207,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":300,"kind":"person","name":"Venkatesan Jay","position":1,"cik":"0001413350","reported_name":"Venkatesan Jay","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-05-27T20:20:09.000Z","date":"2021-02-09","kind":"sale","acquired":false,"shares":159177,"price":16,"value":2546832.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 9, 2021 the Reporting Person exercised a warrant to purchase an aggregate of 396,329 shares of the Issuer's common stock for $6.43 a share. The Reporting Person paid the exercise price on a cashless basis, resulting in the issuer's withholding of 159,177 of the warrant shares to pay the exercise price and issuing to the Reporting Person the remaining 237,152 shares of common stock."}],"balance_after":1367263,"source":{"system":"sec-edgar","filing":"0001601485-22-000045","document":"wf-form4a_165368278065712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1413350/000160148522000045/wf-form4a_165368278065712.xml","form_type":"4/A","original_submission_date":"2021-02-11"}},{"id":2253206,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":300,"kind":"person","name":"Venkatesan Jay","position":1,"cik":"0001413350","reported_name":"Venkatesan Jay","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-05-27T20:20:09.000Z","date":"2021-02-09","kind":"other","acquired":true,"shares":396329,"price":6.43,"value":2548395.47,"ownership":{"direct":true},"balance_after":1598440,"source":{"system":"sec-edgar","filing":"0001601485-22-000045","document":"wf-form4a_165368278065712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413350/000160148522000045/wf-form4a_165368278065712.xml","form_type":"4/A","original_submission_date":"2021-02-11"}},{"id":2253205,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":300,"kind":"person","name":"Venkatesan Jay","position":1,"cik":"0001413350","reported_name":"Venkatesan Jay","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-05-27T20:18:25.000Z","date":"2022-05-25","kind":"purchase","acquired":true,"shares":11313,"price":1.2466,"value":14102.7858,"ownership":{"direct":true},"balance_after":1891947,"source":{"system":"sec-edgar","filing":"0001601485-22-000043","document":"wf-form4_165368268236817.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413350/000160148522000043/wf-form4_165368268236817.xml","form_type":"4"}},{"id":2252994,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":66172,"kind":"person","name":"GANZI VICTOR F","position":1,"cik":"0001199070","reported_name":"GANZI VICTOR F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2022-05-27T16:19:36.000Z","date":"2021-02-09","kind":"other","acquired":false,"shares":614310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 9, 2021 the Reporting Person exercised a warrant to purchase an aggregate of 614,310 shares of the Issuer's common stock for $6.43 a share. The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 246,720 of the warrant shares to pay the exercise price and issued the remaining 367,590 shares of common stock to Reporting Person."}],"balance_after":0,"derivative":{"exercise_price":6.43,"expiration_date":"2028-07-05","underlying":"Common Stock","underlying_shares":614310},"source":{"system":"sec-edgar","filing":"0001601485-22-000044","document":"wf-form4a_165368270982659.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1199070/000160148522000044/wf-form4a_165368270982659.xml","form_type":"4/A","original_submission_date":"2021-02-11"}},{"id":2252993,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":66172,"kind":"person","name":"GANZI VICTOR F","position":1,"cik":"0001199070","reported_name":"GANZI VICTOR F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-27T16:19:36.000Z","date":"2021-02-09","kind":"sale","acquired":false,"shares":246720,"price":16,"value":3947520.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 9, 2021 the Reporting Person exercised a warrant to purchase an aggregate of 614,310 shares of the Issuer's common stock for $6.43 a share. The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 246,720 of the warrant shares to pay the exercise price and issued the remaining 367,590 shares of common stock to Reporting Person."}],"balance_after":823117,"source":{"system":"sec-edgar","filing":"0001601485-22-000044","document":"wf-form4a_165368270982659.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1199070/000160148522000044/wf-form4a_165368270982659.xml","form_type":"4/A","original_submission_date":"2021-02-11"}},{"id":2252992,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":66172,"kind":"person","name":"GANZI VICTOR F","position":1,"cik":"0001199070","reported_name":"GANZI VICTOR F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-27T16:19:36.000Z","date":"2021-02-09","kind":"other","acquired":true,"shares":614310,"price":6.43,"value":3950013.3,"ownership":{"direct":true},"balance_after":1069837,"source":{"system":"sec-edgar","filing":"0001601485-22-000044","document":"wf-form4a_165368270982659.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1199070/000160148522000044/wf-form4a_165368270982659.xml","form_type":"4/A","original_submission_date":"2021-02-11"}},{"id":2256581,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":300,"kind":"person","name":"Venkatesan Jay","position":1,"cik":"0001413350","reported_name":"Venkatesan Jay","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-05-25T21:58:29.000Z","date":"2022-05-24","kind":"purchase","acquired":true,"shares":32200,"price":1.24,"value":39928.0,"ownership":{"direct":true},"balance_after":1721457,"source":{"system":"sec-edgar","filing":"0001601485-22-000039","document":"wf-form4_165351588830337.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1413350/000160148522000039/wf-form4_165351588830337.xml","form_type":"4"}},{"id":2256580,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":300,"kind":"person","name":"Venkatesan Jay","position":1,"cik":"0001413350","reported_name":"Venkatesan Jay","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-05-25T21:58:29.000Z","date":"2022-05-20","kind":"purchase","acquired":true,"shares":50000,"price":1.23,"value":61500.0,"ownership":{"direct":true},"balance_after":1689257,"source":{"system":"sec-edgar","filing":"0001601485-22-000039","document":"wf-form4_165351588830337.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413350/000160148522000039/wf-form4_165351588830337.xml","form_type":"4"}},{"id":2259908,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":312,"kind":"person","name":"Nissenson Allen","position":1,"cik":"0001441889","reported_name":"Nissenson Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-23T23:48:38.000Z","date":"2022-05-20","kind":"purchase","acquired":true,"shares":2037,"price":1.18,"value":2403.66,"ownership":{"direct":true},"balance_after":9383,"source":{"system":"sec-edgar","filing":"0001628280-22-015238","document":"wf-form4_165334970201347.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1441889/000162828022015238/wf-form4_165334970201347.xml","form_type":"4"}},{"id":2259907,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":312,"kind":"person","name":"Nissenson Allen","position":1,"cik":"0001441889","reported_name":"Nissenson Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-23T23:48:38.000Z","date":"2022-05-19","kind":"purchase","acquired":true,"shares":7346,"price":1.16,"value":8521.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.14 to $1.18 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":7346,"source":{"system":"sec-edgar","filing":"0001628280-22-015238","document":"wf-form4_165334970201347.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441889/000162828022015238/wf-form4_165334970201347.xml","form_type":"4"}},{"id":2350066,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":300,"kind":"person","name":"Venkatesan Jay","position":1,"cik":"0001413350","reported_name":"Venkatesan Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-04T21:22:42.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The total number of options vest in equal parts on July 31, 2022 and December 31, 2022, such that 100% of the options will be fully vested and exercisable on December 31, 2022."}],"balance_after":760000,"derivative":{"exercise_price":1.94,"expiration_date":"2032-03-02","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001601485-22-000014","document":"wf-form4_164642894442998.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1413350/000160148522000014/wf-form4_164642894442998.xml","form_type":"4"}},{"id":2350065,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":300,"kind":"person","name":"Venkatesan Jay","position":1,"cik":"0001413350","reported_name":"Venkatesan Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-04T21:22:42.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The total number of options vest in forty-eight (48) successive and equal monthly installments as measured from March 3, 2022 (the \"Vesting Commencement Date\"), such that 100% of the options will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":600000,"derivative":{"exercise_price":1.94,"expiration_date":"2032-03-02","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001601485-22-000014","document":"wf-form4_164642894442998.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413350/000160148522000014/wf-form4_164642894442998.xml","form_type":"4"}},{"id":2349976,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":44236,"kind":"person","name":"CURHAN GREGORY S","position":1,"cik":"0001263244","reported_name":"CURHAN GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-04T21:20:24.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The total number of options vest in forty-eight (48) successive and equal monthly installments as measured from March 3, 2022 (the \"Vesting Commencement Date\"), such that 100% of the options will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":100000,"derivative":{"exercise_price":1.99,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001601485-22-000011","document":"wf-form4_164642880552681.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263244/000160148522000011/wf-form4_164642880552681.xml","form_type":"4"}},{"id":2350313,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":129509,"kind":"person","name":"Neylan John F.","position":1,"cik":"0001640447","reported_name":"Neylan John F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-04T16:21:53.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The total number of options vest in equal parts on July 31, 2022 and December 31, 2022, such that 100% of the options will be fully vested and exercisable on December 31, 2022."}],"balance_after":275000,"derivative":{"exercise_price":1.99,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001601485-22-000013","document":"wf-form4_164642889806390.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640447/000160148522000013/wf-form4_164642889806390.xml","form_type":"4"}},{"id":2350312,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":129509,"kind":"person","name":"Neylan John F.","position":1,"cik":"0001640447","reported_name":"Neylan John F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-04T16:21:53.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The total number of options vest in forty-eight (48) successive and equal monthly installments as measured from March 3, 2022 (the \"Vesting Commencement Date\"), such that 100% of the options will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":175000,"derivative":{"exercise_price":1.99,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001601485-22-000013","document":"wf-form4_164642889806390.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640447/000160148522000013/wf-form4_164642889806390.xml","form_type":"4"}},{"id":2349656,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-04T16:21:14.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The total number of options vest in equal parts on July 31, 2022 and December 31, 2022, such that 100% of the options will be fully vested and exercisable on December 31, 2022."}],"balance_after":275000,"derivative":{"exercise_price":1.99,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001601485-22-000012","document":"wf-form4_164642885246988.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1568249/000160148522000012/wf-form4_164642885246988.xml","form_type":"4"}}],"next_cursor":"2022-03-04T16:21:14.000000Z,2349656"}